Exclusive

Publication

Byline

Location

Trump's 100% drug tariff: India's generics offer safety but a grey zone exists

New Delhi, Sept. 26 -- US President Donald Trump's latest tariff missile imposing a 100% levy on branded or patented pharmaceuticals is unlikely to have much impact on India's drug industry that mostl... Read More


Trump's pharma tariff shock: Why Indian generics may escape the hit-for now

New Delhi, Sept. 26 -- US President Donald Trump's latest tariff missile imposing a 100% levy on branded or patented pharmaceuticals is unlikely to have much impact on India's drug industry that mostl... Read More


Trump's 100% drug tariff: India's generic edge to limit immediate fallout

New Delhi, Sept. 26 -- US President Donald Trump's latest tariff missile imposing a 100% levy on branded or patented pharmaceuticals is unlikely to have much impact on India's drug industry that mostl... Read More


Trump's 100% drug tariff: India's generic edge limits immediate fallout

New Delhi, Sept. 26 -- US President Donald Trump's latest tariff missile imposing a 100% levy on branded or patented pharmaceuticals is unlikely to have much impact on India's drug industry that mostl... Read More